MedTrace Logo

Long Protocol and Growth Hormone in Poor Responders

NCT02338206 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2017-11-29

No results posted yet for this study

Summary

The long down regulation protocol is widely used in the in vitro fertilization cycles, now it will be assessed regarding its efficacy, in poor responder females undergoing in vitro fertilization cycles, alone and after the addition of growth hormone.

Conditions

Interventions

DRUG

Growth hormone

Sponsors & Collaborators

  • Cairo University

    collaborator OTHER

  • Woman's Health University Hospital, Egypt

    lead OTHER

Principal Investigators

  • Dina M Dakhly, MD · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
44 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2017-11-30
Completion
2017-11-15

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02338206 on ClinicalTrials.gov